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Abstract:  Meroterpenes are compounds of mixed biogenesis, isolated from plants, 
microorganisms and marine invertebrates. We have previously isolated and determined the 
structure for a series of meroterpenes extracted from the ascidian Aplidium aff. densum. 
Here, we demonstrate the chemical synthesis of three of them and their derivatives, and 
evaluate their biological activity on two bacterial strains, on sea urchin eggs, and on 
cancerous and healthy human cells. 
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1. Introduction  
 
Meroterpenes are compounds of mixed biosynthesis, mostly quinone or hydroquinones bonded with 
a terpenoid portion ranging from one to nine isoprene units. In the marine environment, these 
secondary metabolites are isolated mainly from: brown algae such as Cystoseira [1], marine 
microorganisms [2], soft corals [3], or marine invertebrates, such as sponges or ascidians [4,5]. Some 
prenylated hydroquinones inhibit proliferation of a panel of cancer cells [6–8]. Moreover, three new 
sesqui- and diterpene hydroquinone MK2 or PI3 kinase inhibitors have been described from 
demosponges [9,10].  
We recently extracted and elucidated the structure for a series of terpene hydroquinones from the 
ascidian Aplidium aff. densum [11]. Three of these secondary metabolites are shown in Figure 1. 
 
Figure 1. Structures of epiconicol (3a), didehydroconicol (4a) and methoxyconidiol (5a). 
 
 
One of these compounds, methoxyconidiol, when tested on sea urchin embryos during cell division, 
disturbs mitotic spindle assembly leading to a cell cycle arrest during metaphase/anaphase transition 
[12]. These promising results led us to synthesize compound 5a, and the natural analogs 3a and 4a, as 
well as the methoxylated derivatives 3b–5b, in order to determine the role of the phenol functions. 
The antiproliferative activity of these products was tested on bacteria (Micrococcus luteus and 
Escherichia coli), sea urchin eggs and normal and cancerous human cells. Considering the severe cell 
cycle disruption produced by methoxyconidiol treatment in sea urchin eggs, we directly evaluated the 
cytotoxicity of these new compounds on a panel of murine and human cells, both healthy and 
cancerous. 
 
2. Results and Discussion  
 
2.1. Chemistry 
 
As previously described by Cruz-Almanza et al., the natural meroterpene 3a and the methoxy 
derivatives 3b–5b were synthesized starting from compounds 2a and 2b, respectively, using acidic 
conditions (Scheme 1) [13]. These two geranylhydroquinone derivatives used as key intermediates Mar. Drugs 2010, 8                 
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were prepared from methoxymethyl (MOM) protected hydroquinone 1a or MOM protected   
4-methoxyphenol 1b by aromatic lithiation and subsequent treatment with citral. The new natural 
meroterpene 5a was synthesized by acidic treatment of 2a in methanol for 24 hours at 8 °C. Reaction 
time (24h) and constant temperature (8 °C) were found to be crucial in obtaining this compound; other 
conditions (room temperature with a shorter reaction time) led to the meroterpene 3a. The compound 
5a was thus synthesized with a yield of 25%. It should be noted that the acidic treatment of 2a and 2b 
promoted dehydration followed by a rearrangement of the corresponding carbocation leading to 
meroterpenes 3a–b or 5a–b. This reaction was found to be diastereoselective with a cis/trans ratio 
greater than 4/1. The pair of cis isomers was purified, and finally, good yields of the new natural 
chromene  4a and its methoxy derivative 4b were obtained (70% yields) from 3a and 3b by 
dehydrogenation in the presence of sulfur at 250 °C. The 
1H and 
13C NMR spectra of compounds 3a, 
4a and 5a were perfectly identical to those of the natural products epiconicol (3a), didehydroconicol 
(4a) and methoxyconidiol (5a) [11]. 
 
Scheme 1. Reagents and conditions: (i) (a) NaH, THF, 1 h, rt, (b) MOMCl, THF, 3 h, rt; 
(ii) (a) nBuLi, THF, 2 h, rt, (b) citral, THF, 24 h, rt; (iii) HCl 6N, mixture 50:   
50 THF/MeOH, 3 h, reflux; (iv) HCl 6N, MeOH, 3 h, rt; (v) HCl 12N, MeOH, 24 h, 8 °C; 
(vi) S, 4 h, 250 °C. 
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2.2. Biological activities 
 
Some meroterpenes, of marine or plant origins, possess biological activities. Among them, 
cordiachromene A moderately inhibits the growth of Micrococus luteus [12], Staphyclococcus aureus 
and  Streptococcus faecalis [14,15]. Hydroquinone sesquiterpenes are reported to be cytotoxic. 
Moreover, several meroterpenes isolated from terrestrial organisms inhibit the proliferation of a panel 
of cancer cells lines [9]. 
We evaluated the biological activities of compounds 3a–5a and their methoxy derivatives 3b–5b. 
Compounds  3b–5b were designed and synthesized because the introduction of a methoxy group 
(instead of a phenolic group) could influence their biological activities. Antibacterial assays were 
carried out on two bacterial strains and antiproliferative assays were carried out against sea urchin eggs 
and a panel of cancerous and healthy cells. 
 
2.2.1. Antibacterial assays 
 
The Microtiter Broth Dilution Method on gram negative (Escherichia coli) and gram positive 
(Micrococcus luteus) bacteria was used [16]. Meroterpenes dissolved in DMSO were added to bacteria 
suspensions (5:100 v:v) for 24 hours. The assay was carried out in triplicate. Bacterial growth was 
evaluated by absorbance measurement (630 nm). The minimum concentration that inhibits (MIC) 
bacterial growth was determined for each compound on each bacterial strain. 
Four of the six meroterpenes had no effect on either of the two bacterial strains. Compounds 3a and 
4a were weakly active. The MIC of epiconicol was 0.8 and 0.1 mM against E. coli and M. luteus 
respectively. Didehydroconicol inhibited the growth of M. luteus with a MIC of 0.5 mM. These two 
compounds possess phenolic group, and their substitution with a methoxy group (compounds 3b and 
4b) led to totally inactive compounds. 
 
2.2.2. Antiproliferative activities 
 
The six meroterpenes were further tested on two models: sea urchin eggs as well as on healthy and 
tumorous human cells. We first assayed the capacity of each compound to inhibit sea urchin egg 
divisions (Paracentrotus lividus and Sphaerechinus granularis). Early sea urchin embryos used to be a 
model organism for antiproliferative screening and identification of cellular targets. In fact, several 
physiological features make this system ideal for conducting a wide range of biological tests. These 
include straight forward artificial spawning, in vitro fertilization, rapid synchronous development, 
embryo optical transparency, and well understood embryogenesis.  
For cytotoxic assays on sea urchins, meroterpenes were dissolved in an egg suspension (described 
in the experimental section), and their ability to inhibit 50% of cell division (IC50) was estimated. Each 
experiment was carried out in triplicate and an average taken. Results are shown in table 1. Mar. Drugs 2010, 8                 
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Table 1. Antiproliferative activity of meroterpenes on sea urchin eggs (Paracentrotus 
lividus and Sphaerechinus granularis). An egg suspension was incubated with the six 
compounds in a 96-well plate. 85 minutes after fertilization (time when 100% division 
occurred in the control eggs), the number of dividing eggs was recorded and IC50 was 
calculated for each compound. Each experiment was carried out in triplicate.  
Compounds IC50 (µM) 
  P. lividus  S.  granularis 
3a  >25.0  9.8 ± 1.3 
3b  >25.0 >25.0 
4a  11.3 ± 0.8  >25.0 
4b  >25.0 >25.0 
5a  4.3 ± 0.1  0.8 ± 0.0 
5b  >25.0 >25.0 
 
Chromane (3a), chromene (4a) and hydroquinone (5a) inhibit egg division, methoxyconidiol (5a) 
being the most active. IC50 of methoxyconidiol was 0.80 µM on P. lividus eggs and   
4.30 µM on S. granularis eggs, while epiconicol (3a) inhibited P. lividus eggs division with a IC50 
value of 9.80 µM and the IC50 of didehydroconicol (4a) was 11.30 µM on P. lividus eggs and was 
inactive on S. granularis eggs. Methoxylated analogs are not active on sea urchin eggs. The 
substitution of a phenolic function with a methoxy group in these compounds produced a total loss  
of activity.  
To provide information on their antiproliferative activity against solid cancers, the six meroterpenes 
were tested on three human carcinoma cell lines corresponding to cancers commonly observed in 
Western countries: MCF7 (breast), PA1 (ovary) and PC3 (prostate). To obtain additional information 
on their specificity for human cell lines and their specificity for cancer versus normal cell lines, each 
compound was tested versus L-929 murine immortalized cells and human normal fibroblasts. To 
mimic what happens in vivo, assays were carried out on exponentially growing cells cultured in the 
presence of 10% serum. The growth inhibitory effect was determined by measuring, after a 48 hour 
exposure to each chemical, the metabolic activity of treated and control cultures using the resazurin 
reduction test (RRT), which measures the amount of fluorescent resofurin produced by living cells. 
The results clearly demonstrated the non toxicity in all cell lines of the three methoxylated analogs 
(3b–5b), didehydroconicol (4a) and methoxyconidiol (5a) with an IC50 > 100 M. A dose-dependent 
inhibition of cell proliferation was only observed for epiconicol (3a). The IC50 of this product varied 
with the cell lines from 37 to 69 M. The toxicity of epiconicol observed in our model is in agreement 
with data obtained by Caroll and co-workers on a panel of cancer cells [17]. 
At 5 µM, epiconicol showed a weak but significant selectivity for PA1 and MCF7 carcinoma cells. 
Accordingly, 30% of the PA1 and MCF7 cultures were killed, while any antiproliferative activity was 
observed on primary fibroblasts or androgen-resistant prostate carcinoma cells (PC3). Data in Figure 2 
showed that for epiconicol, the replacement of the hydroxyl group with a methoxy group suppressed 
the cytotoxicity on PA1, MCF7 and L929 cells and, consequently the selectivity for these cell lines. 
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Figure 2. Effect of the compounds 3a and 3b on cell lines at 5 µM (PA1 ovarian, PC3 
prostatical, MCF7 mammalian, human fibroblast and L929 murine fibroblasts). The 
antiproliferative effect was assessed by an evaluation of metabolical activity (RRT). Each 
experiment was carried out in triplicate. 
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The susceptibility of sea urchin eggs and human cells to methoxyconidiol was compared. 
Methoxyconidiol has the capacity to inhibit the proliferation of sea urchin eggs but not that of human 
cancer cell lines. This may be due either to a problem of penetration through human cell membranes, 
or to the rapid detoxification of methoxyconidiol by human cells inactivating the compound, or to the 
rapid bioconversion of methoxyconidiol by sea urchin eggs activating the compound. 
To test the latter hypothesis, S.s granularis eggs were treated with 5 M of methoxyconidiol, a 
concentration that inhibits their division. Sea urchin eggs were incubated 1, 40 and 90 minutes   
post-fertilization (p.f.) [18] in the presence of methoxyconidiol. Cytoplasmic extracts of treated and 
control eggs were further prepared. Organic extracts of the cytoplasmic preparations were finally 
obtained and analyzed by HPLC (Figure 3). 
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Figure 3. HPLC analysis of methoxyconidiol (System WATERS, column: synergy 4 µm RP 
max; elution water: methanol under a gradient; UV detection 285 nm; flow: 0.3 mL/min) A: 
control compound (methoxyconidiol) B: analysis after Solid Phase Extraction at 1, 40 and   
90 minutes after fertilization (min p.f.).  
 
 
Chromatograms were compared to the one obtained with a pure methoxyconidiol solution. A single 
peak at a characteristic retention time and UV spectrum (photodiode array detection) for 
methoxyconidiol (5a) was observed in cytoplasmic extracts from sea urchin eggs. The level of the 
xenobiotic compound did not decrease significantly during incubation. No other minor compound 
appeared after 40 or 90 minutes of incubation suggesting that the antiproliferative compound on sea 
urchins is methoxyconidiol and not a biotransformed analog. Furthermore, the presence of 
methoxyconidiol on the cytoplasm clearly indicates that the compound penetrates through sea urchin 
cell membranes. Methoxyconidiol was found ineffective on human cancer cells: this can be explained 
by a difference in membrane permeability or intracellular transport of compounds between sea urchin 
cells and human cells, a phenomena previously described for some cells [19,20]. Mar. Drugs 2010, 8                 
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3. Experimental Section  
 
3.1. Chemistry 
 
Commercial reagents were used without further purification. Melting point was determined on a 
Köfler melting point apparatus and is uncorrected. 
1H NMR (400 MHz) and 
13C (100 MHz) were 
recorded on a JEOL EX 400 spectrometer. Chemical shifts are expressed in ppm from the solvent 
chloroform (CDCl3) used as an internal standard: H 7.24 (residual CHCl3), C 77.0 for CDCl3. Mass 
spectrum was recorded on an Automass Benchtop Quadripole Mass Spectrometer. Column 
chromatography was performed on silica gel 60 merck (0.063–0.200 mm). The meroterpenes 3a and 
3b–5b were synthesized as previously described [13]. 
 
Procedures for the preparation of compounds 4a–5a and 4b 
 
Methoxyconidiol (5a). 12 N hydrochloric acid (0.5 mL) was added dropwise to a stirred solution of 
alcohol 2a (0.250 g, 0.7 mmol) in methanol (10 mL). The mixture was cooled at 8 °C for 24 h. The 
solution was diluted with a large excess of water and extracted with CH2Cl2. The combined organic 
layers were washed with water, dried (Na2SO4) and evaporated to produce a yellow oil, which was 
purified by the addition of a 8:2 mixture of ethyl acetate and heptane to furnish compound 5a as a 
white solid (48 mg, 25%). Mp 197 °C. 
1H NMR and 
13C NMR, see reference 11; MS (EI) m/z: 276. 
 
Didehydroconicol (4a). A mixture of compound 3a (0.154 g, 0.63 mmol) and sulfur (0.040 g,   
1.26 mmol) was heated at 250 °C under a nitrogen atmosphere for 4h. The mixture was extracted with 
Et2O (2×10 mL). The solvent was evaporated and the residue was purified by column chromatography 
(heptane/ethyl acetate (8:2)) to furnish compound 4a as a colorless oil (105 mg, 70%). 
1H NMR and 
13C NMR, see reference 11; MS (EI) m/z: 240.  
 
O-methyldidehydroconicol (4b). This compound was prepared from 3b  (0.140 g, 0.54 mmol)  as 
described for 4a. The residue was purified by column chromatography (heptane/ethyl acetate (95:5)) to 
give 4b (96 mg) as a colorless oil with a yield of 70%. 
1H NMR (CDCl3, 400 MHz):  (ppm) 1.59 (s, 
6H), 2.40 (s, 3H), 3.84 (s, 3H), 6.80 (dd, J = 9 Hz and J = 3 Hz), 6.87 (d, J = 9 Hz, 1H), 7.11–7.14 (m, 
2H), 7.24 (d, J = 3 Hz, 1H), 7.49 (s, 1H). 
13C NMR (CDCl3, 100 MHz):  (ppm) 21.4, 27.5, 55.9, 77.3, 
108.0, 115.0, 118.7, 122.9, 123.22, 123.20, 128.6, 128.9, 137.2, 137.3, 146.9, 154.4.   
MS (EI): m/z: 254. 
 
3.2. Biological activities 
 
The antibacterial assay used was based on the previously described method published by the 
National Committee of Laboratory Safety and Standards [11]. Mar. Drugs 2010, 8                 
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3.2.1. Assays on sea urchin eggs 
 
For antiproliferative assays on sea urchin eggs, we used a previously described method [12].
 
 
3.2.1.1. Extraction of methoxyconidiol from treated sea urchin eggs 
 
3.2.1.1.1. Preparation of cytoplasmic extracts 
 
Preparation of cytoplasmic extracts was based on the technique described by Collas and Poccia 
[18]. Gametes of P. lividus were collected in two separate beakers. Sperm was maintained undiluted on 
ice and eggs were stored at 19 °C until use. Sperm was diluted to 10% in Filtered Sea Water (FSW) 
and eggs were at 26 eggs/L in FSW.  
Fertilization was done in the proportion 1:1000 sperm:eggs (v:v). Elevation of the fertilization 
membrane was controlled under an inverted microscope (x10) and when 99% of the eggs were 
fertilized, methoxyconidiol dissolved in DMSO and FSW was added. A control without the addition of 
methoxyconidiol was carried out under the same conditions.  
The cytoplasm of treated and control eggs was extracted just after fertilization, 40 and 90 minutes 
after fertilization. 10 mL of an homogeneous suspension of fertilized eggs was centrifuged at 2000 rpm 
for 5 min at 4 °C. 5 mL of Buffer A (10mM HEPES pH 8.0, 250 mM NaCl, 25 mM EGTA, 5 mM 
MgCl2, 110 mM glycine, 250 mM glycerol, 1 mM DTT and 1 mM PMSF) was added to the pellet and 
centrifuged again under the same conditions. Eggs were resuspended carefully in an ice-cold Buffer A 
at a volume ratio of 1:1 v:v and transferred into a 1.5 mL microcentrifuge tube on ice. To homogenize 
the solution, the eggs suspension was rapidly aspirated into a 3 mL syringe through a 22 gauge needle, 
expelled rapidly into the tube, re-aspirated and re-expelled quickly back into the tube. The lysate was 
centrifuged at 10,000 rpm for 10 min at 4 °C. An aliquot of the clear cytoplasm was taken, frozen in 
liquid nitrogen, and stored at -80 °C until chemical extraction. 
 
3.2.1.1.2. Chemical extraction of methoxyconidiol and HPLC analysis 
 
Cytoplasmic extracts of treated and control eggs were extracted with CH3OH and CH2Cl2 and 
analyzed by HPLC. Small columns of reverse (C18) phase were prepared and conditioned with 
methanol, methanol:water 1:1 (v:v) and water. Cytoplasmic extracts were eluted from the column with 
water to eliminate polar compounds and salts. Methoxyconidiol was eluted with methanol and further 
concentrated. This fraction was analyzed in HPLC (column: Phenomenex synergy 4 max RP; elution 
with water and methanol under gradient, starting from 30% to 0% of water during 15 minutes; flow: 
0.3 mL/min; detection photodiode array, UV at 285 nm).  
 
3.2.1.2. Cell culture and cytotoxicity assay 
 
Human primary fibroblasts were purchased from Biopredic International (Rennes, France). 
Immortalized murine L929 cells and human MCF7 breast adenocarcinoma, PA1 ovary 
teratocarcinoma and PC3 androgen-resistant prostate carcinoma cells were obtained from the European Mar. Drugs 2010, 8                 
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Collection of Cell Cultures (ECACC, Salibury, UK). All were cultured at 37 °C under 5% CO2 and 
maintained in Eagle’s minimum essential medium (Gibco-BRL, Paisley, Scotland) supplemented with 
10% fetal calf serum, vitamins and antibiotics (Gibco
TM, Cergy-Pontoise, France) as described 
previously [21].  
The cytotoxicity of each treatment was determined after a 48 h exposure to each chemical   
(6 concentrations in triplicate, each in DMSO 0.5%) by means of the resazurin reduction test (RRT) 
that measures the amount of fluorescent resorufin produced by living cells. Assays were carried out at 
530/590 nm accordingly to the procedure described by Barthomeuf et al. [21]. IC50  values  
(mean  S.D.) were calculated with the ALLFIT program and were expressed in µM. 
 
4. Conclusions  
 
Previous promising results [12] led us to synthesize six meroterpenes in order to evaluate their 
biological activities on two bacterial strains, on sea urchin eggs and on cancer cell lines. A first 
concern was to investigate the effect of a replacement of the phenolic hydroxyl by a methoxy group. In 
the present study, we conclude that this chemical modification reduced both the antibacterial and the 
antiproliferative activity of meroterpenes on sea urchin eggs and on normal, immortalized and cancer 
cell lines, highlighting the crucial role of the phenolic group at the C-4 position for the toxicity of 
meroterpenes. In contrast to previous findings on sea urchin eggs, methoxyconidiol was almost 
completely inactive on human serum-stimulated cells. We demonstrated that activity on sea urchin 
eggs was due to methoxyconidiol and not due to one of its degradation products. Furthermore, 
epiconicol, the most active compound on human cells, exhibited only medium toxicity on serum-
stimulated carcinoma cells. However, our data found evidence for a relative selectivity of this 
compound on serum-stimulated human MCF7 breast and PA1 ovary carcinoma cells. 
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